-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Earlier, Moderna's RSV Vaccine mRESVIA Approved By FDA For Adults Aged 18–59 With Underlying Health Conditions

Benzinga·06/13/2025 07:07:46
Listen to the news

Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older